Dr. Irina G. Veytsman, MD
- Medicare services, 2024
- 629
- Medicare patients, 2024
- 195
- Part D claims, 2024
- 294
- Publications
- 13
- Clinical trials
- 7
- Practice address
- 50 Irving Street N.W., Washington, DC 20422
- Practice phone
- Call (202) 745-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Veytsman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Irina G. Veytsman is a hematologist and oncologist in Washington, District of Columbia
Dr. Veytsman practices at Washington DC VA Medical Center in Washington, District of Columbia, part of Veterans Health Administration.
Dr. Veytsman's NPI, 1457548307, was assigned on September 25, 2007. Dr. Veytsman holds Pennsylvania license MD452772.
- NPI
- 1457548307NPI Registry (opens in a new tab)
- NPI enumeration date
- September 25, 2007
- NPI status
- Active
- Practice phone
- (202) 745-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 61
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Irina G. Veytsman practices at Washington DC VA Medical Center in Washington, District of Columbia
Dr. Veytsman's primary practice is Washington DC VA Medical Center, at 50 Irving Street N.W., Washington, DC 20422 in The District County. The practice phone is (202) 745-8000.
- Washington DC VA Medical Center50 Irving Street N.W., Washington, DC 20422 · The District CountyPhone(202) 745-8000
Source: Dmand AI Affiliation Data
Dr. Irina G. Veytsman is affiliated with 2 sites of care and 2 medical groups
Dr. Veytsman's primary practice is Washington DC VA Medical Center in Washington, District of Columbia, part of Veterans Health Administration. Dr. Veytsman is also affiliated with Helen M. Simpson Rehabilitation Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Veytsman to 1 more medical group, named with a free account. Dr. Veytsman's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Irina G. Veytsman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Veytsman practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Washington DC VA Medical Center | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Veterans Health Administration and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Irina G. Veytsman is one of 66 hematologists and oncologists in District of Columbia
Hematology and oncology is Dr. Veytsman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Veytsman's licenses on file in 2 states: Pennsylvania and Connecticut.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
- Specialist, Connecticut
Hematologists and oncologists near Dr. Veytsman
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Irina G. Veytsman billed Medicare for 629 services in 2024
CMS data shows 629 Medicare services from Dr. Veytsman across 5 procedure codes in 2024, for 195 Medicare patients. Medicare paid $77,516 for them.
Dr. Veytsman's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 9602024: 62934%
Where Dr. Veytsman's Medicare services took place, 2024
- In an office396%
- In a facility59094%
Dr. Veytsman compared with the District of Columbia median for hematologists and oncologists, 2024
- Dr. Veytsman
- District of Columbia median
- Medicare services
- 629vs 39659% above
- Medicare patients
- 195vs 14931% above
- Part D claims
- 161vs 11441% above
Medians across 62 hematologists and oncologists in District of Columbia with Dmand AI profiles that report each measure.
Dr. Veytsman's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Veytsman?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Veytsman and other hematologists and oncologists in District of Columbia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Irina G. Veytsman treated 195 Medicare patients in 2024, average age 72
CMS counts 195 Medicare patients who saw Dr. Veytsman in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Veytsman's median patient age at 64, with 39% women.
Dr. Veytsman's Medicare patients by age, 2024
Dr. Veytsman's Medicare patients by sex, 2024
- Women9850%
- Men9750%
Chronic conditions among Dr. Veytsman's Medicare patients, 2024
- High blood pressure75%
- High cholesterol70%
- Cancer65%
- Ischemic heart disease45%
- Arthritis43%
- Diabetes41%
- Chronic kidney disease35%
- COPD34%
Share of Medicare patients with each condition. A patient can have several.
Dr. Veytsman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 64
Patient panel by sex, all payers
- Women39%
- Men57%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Irina G. Veytsman wrote 294 Medicare Part D claims in 2024
In 2024, Dr. Veytsman wrote 294 Medicare Part D claims for 74 patients. 69% of them were for generic drugs. CMS names the drug for 161 of them, across 7 drugs with 11 or more claims each, at $322,018 in total drug cost. In 2023, CMS named 236 claims across 10 drugs.
Dr. Veytsman's Part D claims by kind of drug, 2024
- Generic203 claims69%
- Brand-name91 claims31%
Dr. Veytsman's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Veytsman's Part D claims, 2024
- Opioids6%19 of 294 claims
- Antibiotics5%15 of 294 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2362024: 16132%
Drugs named by CMS: 7 in 2024, 10 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Irina G. Veytsman scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Veytsman for performance year 2024, reported as part of a group.
Dr. Veytsman's MIPS scores, performance year 2024
- 94of 100Final score
- 80.3of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 75of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Irina G. Veytsman has 13 publications on record
Dmand AI links 13 papers to Dr. Veytsman, published from 2012 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Antineoplastic Agents. Dr. Veytsman has published most often in Curr Oncol Rep. Dr. Veytsman's most frequent co-authors are Monica Peravali, Kenneth Dale Burman, MD and Jeanny B. Aragon-Ching, MD.
Dr. Veytsman's papers by year, 2012 to 2024
Topics Dr. Veytsman writes about most
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Antineoplastic Agents
- Protein Kinase Inhibitors
- Antibodies, Monoclonal, Humanized
- ErbB Receptors
- Randomized Controlled Trials as Topic
Dr. Veytsman's most frequent co-authors
- Monica Peravali4 shared papers
- Kenneth Dale Burman, MD2 shared papers
- Jeanny B. Aragon-Ching, MD1 shared paper
Recent publications by Dr. Veytsman
See who Dr. Veytsman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Veytsman works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Irina G. Veytsman has worked on 7 clinical trials
Dmand AI links Dr. Veytsman to 7 clinical trials, 4 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Head and Neck Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.
Clinical trials with Dr. Veytsman by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Veytsman's trials
- Carcinoma, Bronchogenic
- Carcinoma, Non-Small-Cell Lung
- Head and Neck Neoplasms
- Small Cell Lung Carcinoma
Investigators on the most trials with Dr. Veytsman
- Roger S. Keresztes, MD5 shared trials
- Fariborze B. Barhamand, MD4 shared trials
- Marta Batus, MD4 shared trials
Recent clinical trials with Dr. Veytsman
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (opens in a new tab)
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) (opens in a new tab)
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) (opens in a new tab)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Irina G. Veytsman received $297 in industry payments from 2016 to 2024
CMS Open Payments shows 8 general payments to Dr. Veytsman from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $135.
General payments to Dr. Veytsman by program year, 2016 to 2024
General payments to Dr. Veytsman by kind, 2016 to 2024
- Food and beverage$28696%
- Education$114%
Companies that paid Dr. Veytsman the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Irina G. Veytsman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Irina G. Veytsman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Irina G. Veytsman's NPI number?
Dr. Irina G. Veytsman's NPI number is 1457548307. It was assigned on September 25, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Irina G. Veytsman?
Dr. Irina G. Veytsman is a hematologist and oncologist in Washington, District of Columbia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Irina G. Veytsman practice?
Dr. Veytsman practices at 50 Irving Street N.W., Washington, DC 20422. Dr. Veytsman's primary practice is Washington DC VA Medical Center in Washington, District of Columbia, part of Veterans Health Administration. Dmand AI also links Dr. Veytsman to 1 medical group.
What is Dr. Irina G. Veytsman's office phone number?
The practice phone on file for Dr. Veytsman is (202) 745-8000.
What is Dr. Irina G. Veytsman's medical license number?
Dr. Veytsman holds Pennsylvania license MD452772, one of the licenses on file in 2 states.
Which states has Dr. Irina G. Veytsman been licensed in?
Dmand AI has state licenses on file for Dr. Veytsman in Pennsylvania and Connecticut.
Which hospitals is Dr. Irina G. Veytsman affiliated with?
Dr. Veytsman practices at Washington DC VA Medical Center in Washington, District of Columbia. Dr. Veytsman is also affiliated with Helen M. Simpson Rehabilitation Hospital.
What medical group is Dr. Irina G. Veytsman part of?
Dr. Veytsman is linked to MedStar Medical Group. Dmand AI links Dr. Veytsman to 1 more medical group.
Does Dr. Irina G. Veytsman accept Medicare?
Yes. CMS data shows Dr. Veytsman billed Medicare for 629 services in 2024.
What is Dr. Irina G. Veytsman's MIPS score?
Dr. Veytsman's MIPS final score for performance year 2024 is 94 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Irina G. Veytsman see?
CMS counts 195 Medicare patients who saw Dr. Veytsman in 2024, with an average age of 72.
What services does Dr. Irina G. Veytsman bill to Medicare?
In 2024, Dr. Veytsman's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and hospital inpatient care (99233).
What drugs does Dr. Irina G. Veytsman prescribe most?
In 2024 Medicare Part D data, Dr. Veytsman's most prescribed drugs by claims were Eliquis, Levothyroxine Sodium and Pantoprazole Sodium.
Has Dr. Irina G. Veytsman received payments from drug or device companies?
CMS Open Payments shows $297 in general payments to Dr. Veytsman from 8 companies from 2016 to 2024. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Irina G. Veytsman been practicing?
Dr. Veytsman graduated from medical school in 1991, 35 years ago.
Does Dr. Irina G. Veytsman do research?
Dmand AI links 13 publications to Dr. Veytsman, published from 2012 to 2024. Dr. Veytsman has worked on 7 clinical trials.
Who does Dr. Irina G. Veytsman publish with?
Dr. Veytsman's most frequent co-authors are Monica Peravali (4 shared papers), Kenneth Dale Burman, MD (2 shared papers) and Jeanny B. Aragon-Ching, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in District of Columbia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card